Skip to content
Home/Companies/MedTech/Arcoma

Arcoma

MedTech·Sweden·Exited 2014·Held 4yr
Entry
2010
Hold
4yr
Exit
2014

Who owns Arcoma?

Arcoma is a Swedish MedTech company, formerly owned by Sunstone Life Science Ventures, exited in 2014 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Sunstone Life Science Ventures
Investor
Sunstone Life Science Ventures
Sunstone Life Science Ventures III · 2007 · VC

Key facts

HQSweden
SectorMedTech
StatusAcquired
Exit Type
IPO
Exit Year
2014

More from Sunstone Life Science Ventures III

Other portfolio companies in the same fund.

MinervaX
MinervaX
Active
BiotechDenmark· 2014
Cantargia
Exited 2015
BiotechSweden· 2013
Opsona Therapeutics
Exited 2019
BiotechIreland· 2013
Follicum
Exited 2014
BiotechSweden· 2012
to Swedish Growth Fund
Galecto
Exited 2020
BiotechDenmark· 2012
Orphazyme
Orphazyme
Exited 2017
BiotechDenmark· 2011
to Eurazeo

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Arcoma?

Arcoma was formerly owned by Sunstone Life Science Ventures, exited in 2014. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue